Elina O. Erra

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Adenovirus type 7d outbreak associated with severe clinical presentation, Finland, February to June 2024.

Adenovirus type 7d outbreak associated with severe clinical presentation, Finland, February to June 2024.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: February 21, 2025

Efficacy and effectiveness of case isolation and quarantine during a growing phase of the COVID-19 epidemic in Finland.

Efficacy and effectiveness of case isolation and quarantine during a growing phase of the COVID-19 epidemic in Finland.

Journal: Scientific reports
Published: June 04, 2022

Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.

Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.

Journal: Vaccine
Published: March 15, 2021

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.

Journal: Expert review of vaccines
Published: July 12, 2015

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.

Journal: Vaccine
Published: July 12, 2013

Dengue in travelers: kinetics of viremia and NS1 antigenemia and their associations with clinical parameters.

Dengue in travelers: kinetics of viremia and NS1 antigenemia and their associations with clinical parameters.

Journal: PloS one
Published: January 02, 2013

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 18, 2012

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 15, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026